Loading clinical trials...
Loading clinical trials...
Predictivity of Attention Test and Executive Functions After Stroke to Predict Depression 3 Months After Stroke.
The purpose of this study is to determine whether cognitive function evaluation (sustained attention, executive functions, working memory) during acute post-stroke is predictive of a 3 months post-stroke depression.
1. Baseline visit: after neurologic stability, 14 days or less after stroke and before discharge. 2. First assessment : 1. Neurologic data: morphologic data (MRI of the brain), stroke severity (NIHSScore), aphasia assessment (Boston Diagnostic Aphasia Examination) if NIHS verbal score ≥1, hemineglect assessment (Bells test). 2. Personal data assessment : i. Socio demographic : age, gender, marital status, employment, level of education ii. Medical history: medical treatments, psychiatric and non psychiatric history. c. Psychiatric assessment i. Mini International Neuropsychiatric Interview - depression ii. Beck Depression Inventory iii. Clinical Global Impression iv. Standardized Assessment of Personality - Abbreviated Scale (SAPAS) v. Fageström-C vi. Alcohol Use Disorders Identification Test (AUDIT-C) d. Cognitive assessment: i. Verbal memory : Dubois's five words ii. Clock drawing test iii. D2test (computerized) iv. Verbal fluency (Cardebat) v. Working memory (digit span WAIS 3) vi. Brixton (computerized) 3. Assessment 3 months after the first assessment. Phone call and psychiatric assessment: MINI depression, Beck Depression Inventory. Barthel index and Quality of Life assessment.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Neurology service
Paris, France
Start Date
May 16, 2017
Primary Completion Date
September 30, 2019
Completion Date
September 30, 2019
Last Updated
May 28, 2021
74
ACTUAL participants
Thymic history
OTHER
Evaluation of the psychiatric disorders
OTHER
Cognitive evaluation
OTHER
Lead Sponsor
Centre Hospitalier St Anne
NCT07294274
NCT06598670
NCT07343284
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions